147 related articles for article (PubMed ID: 23732294)
21. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study.
Schoofs MW; van der Klift M; Hofman A; van Duijn CM; Stricker BH; Pols HA; Uitterlinden AG
J Bone Miner Res; 2004 Sep; 19(9):1490-6. PubMed ID: 15312249
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of osteoporosis in Thai men.
Pongchaiyakul C; Apinyanurag C; Soontrapa S; Soontrapa S; Pongchaiyakul C; Nguyen TV; Rajatanavin R
J Med Assoc Thai; 2006 Feb; 89(2):160-9. PubMed ID: 16579001
[TBL] [Abstract][Full Text] [Related]
23. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density.
García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA
Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083
[TBL] [Abstract][Full Text] [Related]
24. [Decreased bone mineral density and gene polymorphism in primary biliary cirrhosis].
Lakatos PL; Bajnok E; Tornai I; Folhoffer A; Horváth A; Lakatos P; Szalay F
Orv Hetil; 2004 Feb; 145(7):331-6. PubMed ID: 15049048
[TBL] [Abstract][Full Text] [Related]
25. The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.
Napoli N; Rini GB; Serber D; Giri T; Yarramaneni J; Bucchieri S; Camarda L; Di Fede G; Camarda MR; Jain S; Mumm S; Armamento-Villareal R
Bone; 2009 Mar; 44(3):442-8. PubMed ID: 18977467
[TBL] [Abstract][Full Text] [Related]
26. [Effects of body mass index on bone mineral density in men].
Tóth E; Ferenc V; Mészáros S; Csupor E; Horváth C
Orv Hetil; 2005 Jul; 146(28):1489-93. PubMed ID: 16130443
[TBL] [Abstract][Full Text] [Related]
27. Bone mineral density in rural Thai adults living in Khon Kaen province.
Pongchaiyakul C; Rojroongwasinkul N; Chotmongkol R; Kosulwat V; Charoenkiatkul S; Rajatanavin R
J Med Assoc Thai; 2002 Feb; 85(2):235-44. PubMed ID: 12081125
[TBL] [Abstract][Full Text] [Related]
28. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.
Mencej S; Albagha OM; Prezelj J; Kocjan T; Marc J
J Mol Endocrinol; 2008 Jun; 40(6):273-9. PubMed ID: 18502820
[TBL] [Abstract][Full Text] [Related]
29. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the relationship between type 2 diabetes and osteoporosis using Bayesian inference.
Sta Romana M; Li-Yu JT
J Clin Densitom; 2007; 10(4):386-90. PubMed ID: 17993401
[TBL] [Abstract][Full Text] [Related]
31. Relationship between single nucleotide polymorphisms in CYP1A1 and CYP1B1 genes and the bone mineral density and serum lipid profiles in postmenopausal Japanese women taking hormone therapy.
Quan J; Yahata T; Tamura N; Nagata H; Tanaka K
Menopause; 2009; 16(1):171-6. PubMed ID: 18779756
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms in 11β-hydroxysteroid dehydrogenase type 1 correlate with the postdexamethasone cortisol levels and bone mineral density in patients evaluated for osteoporosis.
Siggelkow H; Etmanski M; Bozkurt S; Groβ P; Koepp R; Brockmöller J; Tzvetkov MV
J Clin Endocrinol Metab; 2014 Feb; 99(2):E293-302. PubMed ID: 24285685
[TBL] [Abstract][Full Text] [Related]
33. Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients.
Toptaş B; Kurt Ö; Aydoğan HY; Yaylim I; Zeybek Ü; Can A; Agachan B; Uyar M; Özyavuz MK; Isbir T
Mol Biol Rep; 2013 Nov; 40(11):6519-24. PubMed ID: 24057271
[TBL] [Abstract][Full Text] [Related]
34. ALOX12 gene polymorphisms and serum selenium status in elderly osteoporotic patients.
Al-E-Ahmad A; Parsian H; Fathi M; Faghihzadeh S; Hosseini SR; Nooreddini HG; Mosapour A
Adv Clin Exp Med; 2018 Dec; 27(12):1717-1722. PubMed ID: 30277667
[TBL] [Abstract][Full Text] [Related]
35. Association of polymorphisms in the beta-2 adrenergic receptor gene with fracture risk and bone mineral density.
Veldhuis-Vlug AG; Oei L; Souverein PC; Tanck MW; Rivadeneira F; Zillikens MC; Kamphuisen PW; Maitland-van der Zee AH; de Groot MC; Hofman A; Uitterlinden AG; Fliers E; de Boer A; Bisschop PH
Osteoporos Int; 2015 Jul; 26(7):2019-27. PubMed ID: 25910744
[TBL] [Abstract][Full Text] [Related]
36. Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis.
Olsson A; Oturai DB; Sørensen PS; Oturai PS; Oturai AB
Mult Scler; 2015 Oct; 21(12):1557-65. PubMed ID: 25623251
[TBL] [Abstract][Full Text] [Related]
37. Heritability of bone mineral density in a multivariate family-based study.
Hernandez-de Sosa N; Athanasiadis G; Malouf J; Laiz A; Marin A; Herrera S; Farrerons J; Soria JM; Casademont J
Calcif Tissue Int; 2014 Jun; 94(6):590-6. PubMed ID: 24687525
[TBL] [Abstract][Full Text] [Related]
38. Association of P2Y(2) receptor SNPs with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients.
Wesselius A; Bours MJ; Henriksen Z; Syberg S; Petersen S; Schwarz P; Jørgensen NR; van Helden S; Dagnelie PC
Purinergic Signal; 2013 Mar; 9(1):41-9. PubMed ID: 22773251
[TBL] [Abstract][Full Text] [Related]
39. Relationship between VKORC1 single nucleotide polymorphism 1173C>T, bone mineral density & carotid intima-media thickness.
Fodor D; Bondor C; Albu A; Popp R; Pop IV; Poanta L
Indian J Med Res; 2013 Apr; 137(4):734-41. PubMed ID: 23703341
[TBL] [Abstract][Full Text] [Related]
40. Association between SNPs and haplotypes in the METTL21C gene and peak bone mineral density and body composition in Chinese male nuclear families.
Zhao F; Gao LH; Li SS; Wei ZY; Fu WZ; He JW; Liu YJ; Hu YQ; Dong J; Zhang ZL
J Bone Miner Metab; 2017 Jul; 35(4):437-447. PubMed ID: 27628047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
